SCHEMBL27426303

SCHEMBL27426303

CC1CN2CCCC2(CC(C)(C)C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27117078 0.81 SCN9A (0.35) —
SCHEMBL10994358 0.80 — —
SCHEMBL26197003 0.80 — —
SCHEMBL26727877 0.80 KRAS (0.31) —
SCHEMBL26580945 0.80 KRAS (0.31) —
SCHEMBL26580623 0.80 KRAS (0.31) —
SCHEMBL26727866 0.80 KRAS (0.31) —
SCHEMBL26727878 0.80 KRAS (0.31) —
SCHEMBL24698529 0.79 — —
SCHEMBL24649368 0.79 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240217982-A1 KRAS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2024-07-04 — — US disclosed
Send feedback